Immuron Limited
IMRN · NASDAQ
6/30/2025 | 3/31/2025 | 12/30/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.07 | -0.02 | 0.06 |
| FCF Yield | -13.84% | -6.38% | -21.77% | -8.89% |
| EV / EBITDA | -4.48 | -10.09 | -4.24 | -11.71 |
| Quality | ||||
| ROIC | -34.79% | -17.09% | -24.22% | -12.11% |
| Gross Margin | 64.02% | 64.02% | 66.52% | 66.52% |
| Cash Conversion Ratio | 0.78 | 0.79 | 1.60 | 1.60 |
| Growth | ||||
| Revenue 3-Year CAGR | 109.87% | 123.61% | 94.25% | 45.30% |
| Free Cash Flow Growth | -100.00% | 73.16% | -100.00% | -3.02% |
| Safety | ||||
| Net Debt / EBITDA | 0.95 | 1.94 | 3.00 | 5.99 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.67 | 0.33 | 0.88 | 0.44 |
| Cash Conversion Cycle | 40.09 | 159.61 | 41.30 | 82.59 |